Lu H, Stratton CW and Tang YW: Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 92:401–402. 2020. View Article : Google Scholar : PubMed/NCBI

Wang X, Zhang X and He J: Challenges to the system of reserve medical supplies for public health emergencies: Reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China. Biosci Trends. 14:3–8. 2020. View Article : Google Scholar : PubMed/NCBI

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al: A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 382:727–733. 2020. View Article : Google Scholar : PubMed/NCBI

Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG and Khan K: Potential for global spread of a novel coronavirus from China. J Travel Med. 27:taaa0112020. View Article : Google Scholar : PubMed/NCBI

Corman VM, Lienau J and Witzenrath M: Coronaviruses as the cause of respiratory infections. Internist (Berl). 60:1136–1145. 2019.(In German). View Article : Google Scholar : PubMed/NCBI

Grifoni A, Sidney J, Zhang Y, Scheuermann RH, Peters B and Sette A: A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2. Cell Host Microbe. 27:671–680.e2. 2020. View Article : Google Scholar : PubMed/NCBI

Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, et al: A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome. N Engl J Med. 348:1953–1966. 2003. View Article : Google Scholar : PubMed/NCBI

Reguera J, Mudgal G, Santiago C and Casasnovas JM: A structural view of coronavirus-receptor interactions. Virus Res. 94:3–15. 2014. View Article : Google Scholar

Huang X, Dong W, Milewska A, Golda A, Qi Y, Zhu QK, Marasco WA, Baric RS, Sims AC, Pyrc K, et al: Human coronavirus HKU1 spike protein uses O-Acetylated sialic acid as an attachment receptor determinant and employs hemagglutinin-esterase protein as a receptor-destroying enzyme. J Virol. 89:7202–7213. 2015. View Article : Google Scholar : PubMed/NCBI

Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, et al: Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 133:1025–1031. 2020. View Article : Google Scholar : PubMed/NCBI

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020. View Article : Google Scholar : PubMed/NCBI

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 395:507–513. 2020. View Article : Google Scholar : PubMed/NCBI

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395:497–506. 2020. View Article : Google Scholar : PubMed/NCBI

Guan WJ and Zhong NS: Clinical characteristics of Covid-19 in China. Reply. N Engl J Me. 382:1861–1862. 2020.

Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li XM, Liu XY, Liu HM, Guo Z, Ren H and Wang Q: Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. Mar;17:10.1002/jmv.25767. 2020. View Article : Google Scholar

Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M and Kitas GD: The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 39:345–357. 2019. View Article : Google Scholar : PubMed/NCBI

Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G and Dimopoulos MA: Hematological findings and complications of COVID-19. Am J Hematol. 95:834–847. 2020. View Article : Google Scholar : PubMed/NCBI

Singhal T: A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 87:281–286. 2020. View Article : Google Scholar : PubMed/NCBI

Yang M, Hon KL, Li K, Fok TF and Li CK: The effect of SARS coronavirus on blood system: Its clinical findings and the pathophysiologic hypothesis. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 11:217–221. 2003.PubMed/NCBI

Al-Tawfiq JA, Hinedi K, Abbasi S, Babiker M, Sunji A and Eltigani M: Hematologic, hepatic, and renal function changes in hospitalized patients with Middle East respiratory syndrome coronavirus. Int J Lab Hematol. 39:272–278. 2017. View Article : Google Scholar : PubMed/NCBI

Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, et al: Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 63:364–374. 2020. View Article : Google Scholar : PubMed/NCBI

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, et al: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720. 2020. View Article : Google Scholar : PubMed/NCBI

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 395:1054–1062. 2020. View Article : Google Scholar : PubMed/NCBI

Lippi G, Plebani M and Henry BM: Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 506:145–148. 2020. View Article : Google Scholar : PubMed/NCBI

Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, et al: Coronavirus infections and immune responses. J Med Virol. 92:424–432. 2020. View Article : Google Scholar : PubMed/NCBI

Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J, Deng Y and Wei S: Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 43:E0052020.(In Chinese). PubMed/NCBI

Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, et al: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet. 395:514–523. 2020. View Article : Google Scholar : PubMed/NCBI

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L, Shan H, Lei CL, Hui DSC, et al: Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv. Jan 1;2020.02.06.20020974. 2020.

Arachchillage DRJ and Laffan M: Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 18:1233–1234. 2020. View Article : Google Scholar : PubMed/NCBI

Yang M, Ng MH, Li CK, Chan PKS, Liu C, Ye JY and Chong BH: Thrombopoietin levels increased in patients with severe acute respiratory syndrome. Thromb Res. 122:473–477. 2008. View Article : Google Scholar : PubMed/NCBI

Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S and Yuen KY: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 9:221–236. 2020. View Article : Google Scholar : PubMed/NCBI

Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T and Chen Q: High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 12:82020. View Article : Google Scholar : PubMed/NCBI

Collins AR: In vitro detection of apoptosis in monocytes/macrophages infected with human coronavirus. Clin Diagn Lab Immunol. 9:1392–1395. 2002.PubMed/NCBI

Yang M, Li K, Chui CMY, Yuen PMP, Chan PK, Chuen CK, Li CK and Fok TF: Expression of interleukin (IL) 1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression. Br J Haematol. 111:371–380. 2000. View Article : Google Scholar : PubMed/NCBI

Yang M, Khachigian LM, Hicks C, Chesterman CN and Chong BH: Identification of PDGF receptors on human megakaryocytes and megakaryocytic cell lines. Thromb Haemost. 78:892–896. 1997. View Article : Google Scholar : PubMed/NCBI

Kontoyiannis DP, Pasqualini R and Arap W: Aminopeptidase N inhibitors and SARS. Lancet. 361:15582003. View Article : Google Scholar : PubMed/NCBI

Wentworth DE and Holmes KV: Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): Influence of N-linked glycosylation. J Virol. 75:9741–9752. 2001. View Article : Google Scholar : PubMed/NCBI

Hammarström S: The carcinoembryonic antigen (CEA) family: Structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol. 9:67–81. 1999. View Article : Google Scholar : PubMed/NCBI

Liu W and Li H: COVID-19: Attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. ChemRxiv. 2020.

Scaradavou A: HIV-related thrombocytopenia. Blood Rev. 16:73–76. 2002. View Article : Google Scholar : PubMed/NCBI

Nardi M, Tomlinson S, Greco MA and Karpatkin S: Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell. 106:551–561. 2001. View Article : Google Scholar : PubMed/NCBI

Yang M, Li CK, Li K, Hon KL, Ng MH, Chan PK and Fok TF: Hematological findings in SARS patients and possible mechanisms (review). Int J Mol Med. 14:311–315. 2004.PubMed/NCBI

Taichman RS: Blood and bone: Two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood. 105:2631–2639. 2005. View Article : Google Scholar : PubMed/NCBI

Ru YX, Dong SX, Zhao SX, Li Y, Liang HY, Zhang MMF, Zhu X and Zheng Y: One cell one niche: Hematopoietic microenvironments constructed by bone marrow stromal cells with fibroblastic and histiocytic features. Ultrastruct Pathol. 43:117–125. 2019. View Article : Google Scholar : PubMed/NCBI

Lord BI: The architecture of bone marrow cell populations. Int J Cell Cloning. 331:317–331. 1990. View Article : Google Scholar

Kiel MJ, Yilmaz ÖH, Iwashita T, Yilmaz OH, Terhorst C and Morrison SJ: SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 121:1109–1121. 2005. View Article : Google Scholar : PubMed/NCBI

Sugiyama T, Kohara H, Noda M and Nagasawa T: Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 25:977–988. 2006. View Article : Google Scholar : PubMed/NCBI

Hamming I, Timens W, Bulthuis ML, Lely AT, Navis GJ and van Goor H: Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 203:631–637. 2004. View Article : Google Scholar : PubMed/NCBI

Ye J, Zhang B, Xu J, Chang Q, McNutt MA, Korteweg C, Gong E and Gu J: Molecular pathology in the lungs of severe acute respiratory syndrome patients. Am J Pathol. 170:538–545. 2007. View Article : Google Scholar : PubMed/NCBI

Mei H and Hu Y: Characteristics, causes, diagnosis and treatment of coagulation dysfunction in patients with COVID-19. Zhonghua Xue Ye Xue Za Zhi. 41:185–191. 2020.(In Chinese). PubMed/NCBI

Panesar NS: What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid-treated patients? Med Hypotheses. 71:298–301. 2008. View Article : Google Scholar : PubMed/NCBI

Lefrançais E, Ortiz-Muñoz G, Caudrillier A, Mallavia B, Liu F, Sayah DM, Thornton EE, Headley MB, David T, Coughlin SR, et al: The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 544:105–109. 2017. View Article : Google Scholar : PubMed/NCBI

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al: Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 8:420–422. 2020. View Article : Google Scholar : PubMed/NCBI

Niinikoski J, Goldstein R, Linsey M and Hunt TK: Effect of oxygen-induced lung damage on tissue oxygen supply. Acta Chir Scand. 139:591–595. 1973.PubMed/NCBI

Yang M, Ng MH and Li CK: Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology. 10:101–105. 2005. View Article : Google Scholar : PubMed/NCBI

LeVine DN, Cianciolo RE, Linder KE, Bizikova P, Birkenheuer AJ, Brooks MB, Salous AK, Nordone SK, Bellinger DA, Marr H, et al: Endothelial alterations in a canine model of immune thrombocytopenia. Platelets. 30:88–97. 2019. View Article : Google Scholar : PubMed/NCBI

Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, Sun R, Tian Z, Xu X and Wei H: Aberrant pathogenic GM-CSF⁺ T cells and inflammatory CD14⁺CD16⁺ monocytes in severe pulmonary syndrome patients of a new coronavirus. bioRxiv. Feb 20–2020.(Epub ahead of print). doi: 10.1101/2020.02.12.945576.

Moore BJ and June CH: Cytokine release syndrome in severe COVID-19. Science. 368:473–474. 2020. View Article : Google Scholar : PubMed/NCBI

Hirano T and Murakami M: COVID-19: A new virus, but a familiar receptor and cytokine release syndrome. Immunity. 52:731–733. 2020. View Article : Google Scholar : PubMed/NCBI

Cohen J: The immunopathogenesis of sepsis. Nature. 420:885–891. 2002. View Article : Google Scholar : PubMed/NCBI

Goldbergers A, Middletons KA, Oliver JA, Paddock C, Yan H, Delissero HM, Albelda SM and Newman PJ: Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J Biol Chem. 269:17183–17191. 1994.PubMed/NCBI

Chaves J, Huen A, Bueso-Ramos C, Safdar A and Vadhan-Raj S: Aerosolized Ribavirin-induced reversible hepatotoxicity in a hematopoietic stem cell transplant recipient with Hodgkin lymphoma. Clin Infect Dis. 42:e72–e75. 2006. View Article : Google Scholar : PubMed/NCBI

Savarino A, Di Trani L, Donatelli I and Cauda Rand Cassone A: New insights into the antiviral effects of chloroquine. Lancet Infect Dis. 6:67–69. 2006. View Article : Google Scholar : PubMed/NCBI

Yan Y, Zou Z, Sun Y, Li X, Xu KF, Wei Y, Jin N and Jiang C: Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res. 23:300–302. 2013. View Article : Google Scholar : PubMed/NCBI

Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG and Nichol ST: Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2:692005. View Article : Google Scholar : PubMed/NCBI

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W and Xiao G: Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30:269–271. 2020. View Article : Google Scholar : PubMed/NCBI

Gao J, Tian Z and Yang X: Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 14:72–73. 2020. View Article : Google Scholar : PubMed/NCBI

Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, Li Y, Hu Z, Zhong W and Wang M: Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 6:162020. View Article : Google Scholar : PubMed/NCBI

Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, et al: Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 56:1059492020. View Article : Google Scholar : PubMed/NCBI

Zhou D, Dai SM and Tong Q: COVID-19: A recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 75:1667–1670. 2020. View Article : Google Scholar : PubMed/NCBI

Siegel D, Hui HC, Doerffler E, Clarke MO, Chun K, Zhang L, Neville S, Carra E, Lew W, Ross B, et al: Discovery and synthesis of a phosphoramidate prodrug of a Pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of ebola and emerging viruses. J Med Chem. 60:1648–1661. 2017. View Article : Google Scholar : PubMed/NCBI

Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, Leist SR, Pyrc K, Feng JY, Trantcheva I, et al: Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 9:eaal36532017. View Article : Google Scholar : PubMed/NCBI

Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, Smith EC, Case JB, Feng JY, Jordan R, et al: Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio. 9:e00221–18. 2018. View Article : Google Scholar : PubMed/NCBI

Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, Lusakibanza Manzo M, Nzolo D, Tshomba Oloma A, Ibanda A, et al: A randomized, controlled trial of ebola virus disease therapeutics. N Engl J Med. 381:2293–2303. 2019. View Article : Google Scholar : PubMed/NCBI

Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, et al: First case of 2019 novel coronavirus in the United States. N Engl J Med. 382:929–936. 2020. View Article : Google Scholar : PubMed/NCBI

Akutagawa K, Fujita T, Ouhara K, Takemura T, Tari M, Kajiya M, Matsuda S, Kuramitsu S, Mizuno N, Shiba H and Kurihara H: Glycyrrhizic acid suppresses inflammation and reduces the increased glucose levels induced by the combination of Porphyromonas gulae and ligature placement in diabetic model mice. Int Immunopharmacol. 68:30–38. 2019. View Article : Google Scholar : PubMed/NCBI

Yan S, Fang C, Cao L, Wang L, Du J, Sun Y, Tong X, Lu Y and Wu X: Protective effect of glycyrrhizic acid on cerebral ischemia/reperfusion injury via inhibiting HMGB1-mediated TLR4/NF-κB pathway. Biotechnol Appl Biochem. 66:1024–1030. 2019. View Article : Google Scholar : PubMed/NCBI

Chen S, Cui G, Peng C, Lavin MF, Sun X, Zhang E, Yang Y, Guan Y, Du Z and Shao H: Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats. Stem Cell Res Ther. 9:1102018. View Article : Google Scholar : PubMed/NCBI

Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H and Doerr HW: Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 361:2045–2046. 2003. View Article : Google Scholar : PubMed/NCBI

Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S, et al: Transplantation of ACE2(−) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 11:216–228. 2020. View Article : Google Scholar : PubMed/NCBI

Cao Y, Wei J, Zou L, Jiang T, Wang G, Chen L, Huang L, Meng F, Huang L, Wang N, et al: Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol. 146:137–146.e3. 2020. View Article : Google Scholar : PubMed/NCBI